Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice

Journal of Neurosurgery

Volumn 105 PEDIATRICS, Issue SUPPL. 4, 2006, Pages 306-310

  Xu, Jianguo ^a   You, Chao ^b   Zhang, Sizhong ^b   Huang, Siqing ^b   Cai, Bowen ^b   Wu, Zhenggui ^b   Li, Hao ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Angiogenesis; Animal model; Cell proliferation; Craniopharyngioma; Mouse; Pediatric neurosurgery; Xenograft

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; MINICHROMOSOME MAINTENANCE DEFICIENT 6; PEROXIDASE; STREPTAVIDIN; TUMOR MARKER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; CRANIOPLASTY; EPITHELIUM TUMOR; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROCIRCULATION; MOUSE; NONHUMAN; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR CELL; VASCULARIZATION; XENOGRAFT;

EID: 33845707669     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/ped.2006.105.4.306     Document Type: Article

References (40)

1. Bullard DE, Bigner DD: Heterotransplantation of human craniopharyngiomas in athymic "nude" mice. Neurosurgery 4:308-314, 1979
2. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM: The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547-551, 1998
3. Caldarelli M, di Rocco C, Papacci F, Colosimo C Jr: Management of recurrent craniopharyngioma. Acta Neurochir (Wien) 140:447-454, 1998
4. Demirag F, Ünsal E, Yilmaz A, Çaǧlar A: Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Chest 128:3382-3387, 2005
5. De Vile CJ, Grant DB, Kendall BE, Neville BGR, Stanhope R, Watkins KE, et al: Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 85:73-81, 1996
6. Dusik-Sharpe J: Kerry's story: the challenges of facing a recurrent craniopharyngioma. Axon 26:8-12, 2004
7. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al: Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27:1554-1562, 1998
8. Goldberg GM, Eshbaugh DE: Squamous cell nests of the pituitary gland as related to the origin of craniopharyngiomas. A study of their presence in newborns and infants to age four. Arch Pathol 70:293-299, 1960
9. Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192:557-564, 2000
10. Grobben B, De Deyn PP, Slegers H: Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270, 2002
11. Gutmann DH, Baker SJ, Giovannini M, Garbow J, Weiss W: Mouse models of human cancer consortium symposium on nervous system tumors. Cancer Res 63:3001-3004, 2003
12. Holland EC: Brain tumor animal models: importance and progress. Curr Opin Oncol 13:143-147, 2001
13. Honegger J, Renner C, Fahlbusch R, Adams EF: Progesterone receptor gene expression in craniopharyngiomas and evidence for biological activity. Neurosurgery 41:1359-1364, 1997
14. Huang P, Taghian A, Allam A, Freeman J, Duffy M, Suit H: The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft. Radiat Res 145:337-342, 1996
15. Jiang R, Liu Z, Zhu C: [Culture of craniopharyngioma cell in vitro and supression effect of Belomycin on the tumor.] Chin J Neurosurg 17:29-31, 2001(Chn)
16. Li SQ: [Craniopharyngioma], in Xu QW, Jiang YP (eds): [Clinical Craniocerebral Disease.] Tianjin: Science & Technology Press, 2003, pp 278-286 (Chn)
17. Matsuo M, Yonemitsu N, Zaitsu M, Ishii K, Hamasaki Y, Fukuyama K, et al: Expression of prostaglandin H synthase-2 in human brain tumors. Acta Neuropathol 102:181-187, 2001
18. Méndez J, Stillman B: Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 20:8602-8612, 2000
19. Mennel HD: Significance of experimental models in neurooncology. Neurosurg Rev 3:129-137, 1980
20. Müller HL, Kaatsch P, Warmuth-Metz M, Flentje M, Sörenson N: [Childhood craniopharyngioma: current concepts in diagnostics and therapy.] Monatsschr Kinderheilkd 151:1056-1063, 2003 (Ger)
21. Nelson GA, Bastian FO, Schlitt M, White RL: Malignant transformation in craniopharyngioma. Neurosurgery 22:427-429, 1988
22. Peterson DL, Sheridan PJ, Brown WE Jr: Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 80:865-876, 1994
23. Plate KH: Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58:313-320, 1999
24. Raghavan R, Dickey WT Jr, Margraf LR, White CL III, Coimbra C, Hynan LS, et al: Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children. Surg Neurol 54:241-248, 2000
25. Rice JM: Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models. Toxicol Appl Pharmacol 199:175-191, 2004
26. Rickert CH, Paulus W: Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngioma. J Neurol Neurosurg Psychiatry 74:260-261, 2003
27. Sachs DH: The immunologic response to xenografts. ILAR J 37:16-22, 1995
28. Schrader C, Janssen D, Klapper W, Siebmann JU, Meusers P, Brittinger G, et al: Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer 93:939-945, 2005
29. Schwed G, May N, Pechersky Y, Calvi BR: Drosophila minichromosome maintenance 6 is required for chorion gene amplification and genomic replication. Mol Biol Cell 13:607-620, 2002
30. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, et al: Craniopharyngiomas of adamantinomatous type harbor b-catenin gene mutations. Am J Pathol 161:1997-2001, 2002
31. Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, et al: Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58:714-720, 2004
32. Sweet WH: Craniopharyngiomas: a summary of data, in Schmidek HH (ed): Schmidek & Sweet Operative Neurosurgical Techniques. Indications, Methods, and Results, ed 4. London: Elsevier, 2002, Vol 1, pp 477-486
33. Taghian A, Huang P: The nude and SCID mice as a tumor model in experimental cancer biology. Cancer J 8:52-58, 1995
34. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, et al: Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132:541-546, 1997
35. Tavangar SM, Larijani B, Mahta A, Seyed SMA, Mehrazine M, Bandarian F: Craniopharyngioma: a clinicopathological study of 141 cases. Endocr Pathol 15:339-344, 2004
36. Van Effenterre R, Boch AL: Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97:3-11, 2002
37. Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW: Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94:738-745, 2002
38. Vyramuthu N, Benton TF: The management of craniopharyngioma. Clin Radiol 34:629-632, 1983
39. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19, 1995
40. Xin W, Rubin MA, McKeever PE: Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 126:1174-1178, 2002